Healthcare Operations

340B Compliance Without the Fire Drill: Pharmacy Split-Billing on Databricks with Agentic AI

Mid-market hospital pharmacies struggle to run compliant 340B split-billing across fragmented EHR, wholesaler, and TPA systems, turning audits into fire drills. This article outlines how to implement governed, agentic AI on the Databricks Lakehouse to encode policy-as-data, reconcile accumulators to purchases with full lineage, and auto-assemble audit-ready evidence. A practical 30/60/90-day plan shows how to pilot and scale, reducing write-offs, false positives, and audit prep time.

• 8 min read

340B Compliance Without the Fire Drill: Pharmacy Split-Billing on Databricks with Agentic AI

1. Problem / Context

Hospital pharmacies running 340B programs juggle split-billing, diversion detection, and accumulator reconciliation across EHR, wholesaler, and third‑party administrator systems. Finance and compliance leaders live with audit stress: reconciling every purchase to eligible dispenses, isolating mixed‑use, and proving the logic behind each accumulator entry. When these steps rely on spreadsheets, static reconciliations, or brittle scripts, write‑offs creep up and audit prep turns into a last‑minute fire drill.

Mid‑market providers face the strain most acutely. Teams are lean, systems are fragmented, and policy changes are frequent. A missed eligibility nuance or an untraceable accumulator adjustment can trigger diversion findings or penalties. The goal is simple but hard: accurate split‑billing with end‑to‑end traceability and faster, cleaner audit readiness.

2. Key Definitions & Concepts

  • 340B: A federal program enabling eligible covered entities to purchase outpatient drugs at reduced prices. Compliance hinges on preventing diversion and duplicate discounts, and on maintaining accurate accumulators for replenishment.
  • Split‑billing: Allocating drug purchases across 340B, GPO, and WAC accounts, especially in mixed‑use settings where inpatient and outpatient activity intermix.
  • Accumulator: The inventory “bank” of eligible dispenses that authorizes 340B replenishment; must be backed by eligibility logic (location, prescriber, encounter type, payer exclusions, etc.).
  • Diversion: Use of 340B drugs for ineligible patients, locations, or encounters.
  • Agentic AI: A governed automation approach where AI‑powered agents reason across multiple data sources, apply policy rules, take actions (e.g., reconcile, flag, draft evidence), and escalate exceptions with a human‑in‑the‑loop.
  • Databricks Lakehouse: A unified platform to ingest, clean, and govern data (Delta tables, Unity Catalog), with orchestration and ML capabilities that support traceable, versioned workflows.

3. Why This Matters for Mid-Market Regulated Firms

For $50M–$300M organizations, every basis point of drug spend matters—and so does audit exposure. The challenge isn’t just automating steps; it’s orchestrating cross‑system reasoning with full traceability. Naive RPA can copy fields between systems but misses edge‑case eligibility logic, leading to false positives and write‑offs. Compliance officers need versioned rules, visible lineage, and evidence packets that stand up to scrutiny, while operations teams need faster cycle times without sacrificing control.

4. Practical Implementation Steps / Roadmap

1) Land and organize data on Databricks

  • Ingest wholesaler invoices/867 files, EHR/dispensing data, eligibility rosters, and TPA accumulator feeds into Delta tables.
  • Normalize NDCs to 11‑digit format, align package sizes, units, and contract identifiers. Establish master references for locations, prescribers, and service lines.

2) Encode eligibility and replenishment policies

  • Maintain rule tables for location eligibility, prescriber types, outpatient encounter definitions, payer exclusions, and manufacturer restrictions.
  • Version rules with effective dates. Keep policy-as‑data so changes are auditable and reproducible.

3) Build reconciliations that mirror how audits ask questions

  • Link each dispense to eligibility (who, where, when) and to the correct account (340B/GPO/WAC).
  • Reconcile accumulators to purchases with explicit evidence: transaction IDs, timestamps, rule snapshots, and unit conversions.

4) Introduce agentic orchestration

  • Agents coordinate across purchasing, dispensing, eligibility, and accumulator tables.
  • The Diversion Agent flags probable diversion (e.g., location mismatch, inpatient window overlap) and drafts a case with evidence references.
  • The Reconciliation Agent proposes split‑billing adjustments and replenishment orders, including unit‑of‑measure conversions and contract attribution.
  • The Audit Agent assembles packets: data lineage, rule versions, exhibits (e.g., encounter type, prescriber credentials), and a narrative of decisions.

5) Human‑in‑the‑loop approvals and segregation of duties

  • Route exceptions to pharmacy compliance for approval via a workflow tool; record decisions back into Delta with user/time stamps.
  • Separate configuration (policy tables) from operations (recon runs) and from approvals to maintain controls.

6) Operationalize

  • Schedule jobs, monitor SLA dashboards, and write approved replenishment suggestions back to wholesaler portals or TPA interfaces.
  • Roll out incremental scopes: start with one service line or a subset of NDCs before expanding.

[IMAGE SLOT: agentic AI workflow diagram for 340B split-billing on Databricks connecting EHR/dispensing, wholesaler 867, TPA accumulators, and policy tables, with human-in-loop approvals]

5. Governance, Compliance & Risk Controls Needed

  • End‑to‑end trace logs: Persist rule versions, query hashes, input snapshots, and outputs so any decision is replayable.
  • Unity Catalog permissions: Enforce least privilege; mask PHI fields; restrict write access to policy tables; log access attempts.
  • Segregation of duties: Different personas for policy authors, operations, and approvers. Require approvals for override actions.
  • Monitoring and alerting: Track accumulator drift, exception rates, and SLA adherence. Escalate when patterns suggest rule gaps or data quality issues.
  • Vendor lock‑in avoidance: Keep rules as data in open Delta tables, use Databricks Jobs/Workflows instead of brittle UI‑bound RPA, and expose evidence via standard notebooks and dashboards.
  • Model and rule lifecycle: Register models (if used) and version rule sets; tie every audit packet to specific versions and validation results.

[IMAGE SLOT: governance and compliance control map showing Unity Catalog permissions, policy-as-data tables, trace logs, and approval workflow with audit trail]

6. ROI & Metrics

Measure improvements in the same language finance and compliance use:

  • Write‑offs: Programs adopting agentic reconciliation have reduced write‑offs by 18%, driven by better eligibility mapping and fewer reconciliation gaps.
  • Audit prep time: Automated packet assembly and traceability cut audit preparation time by 60%.
  • False positives: Smarter eligibility logic and cross‑system reasoning reduce false diversion flags by 35%, lowering compliance workload.
  • Cycle time: Track the duration from dispense to replenishment authorization; target double‑digit reductions by eliminating manual handoffs.
  • Claims accuracy: Monitor the share of dispenses that reconcile cleanly on the first pass.

Example payback math: If your 340B program yields $5M in annual savings and historical write‑offs were 6% ($300k), an 18% reduction recovers roughly $54k/year. Add labor savings from a 60% reduction in audit prep (e.g., 400 hours down to 160 hours) and reduced exception handling from 35% fewer false positives; the combined savings often fund the initial build within the fiscal year.

[IMAGE SLOT: ROI dashboard visualizing write-off reduction (18%), audit prep time reduction (60%), and false-positive reduction (35%) with cycle-time trendlines]

7. Common Pitfalls & How to Avoid Them

  • Naive RPA: Copy‑and‑paste bots miss edge‑case eligibility and provide little lineage. Use agentic logic with policy‑as‑data and evidence generation.
  • Stale eligibility rules: Tie rules to effective dates and require approvals for changes; monitor drift and outliers.
  • NDC and unit conversions: Normalize to 11‑digit NDC, capture package sizes, and document UOM conversions in evidence.
  • Mixed‑use blind spots: Explicitly handle inpatient/outpatient crossover windows and location granularity.
  • Accumulator drift: Reconcile accumulators to purchases on a schedule with alerts for variance thresholds.
  • Lack of traceability: Without end‑to‑end logs, pilots stall in “pilot graveyard.” Build traceability from day one to drive adoption.

30/60/90-Day Start Plan

First 30 Days

  • Discovery: Inventory data sources (EHR/dispense, wholesaler, TPA, eligibility). Map current split‑billing process and audit requirements.
  • Data checks: Land sample feeds in Delta; validate NDC normalization, encounter typing, and prescriber mapping.
  • Governance boundaries: Stand up Unity Catalog, define personas/permissions, and establish approval workflows and change control for rule tables.

Days 31–60

  • Pilot workflows: Implement end‑to‑end for one service line—including agentic reconciliation, diversion flagging, and packet assembly.
  • Security controls: Enable PHI masking, access logging, and row‑level filters. Configure monitoring for accumulator drift and exception spikes.
  • Evaluation: Compare pilot metrics to baseline (write‑offs, cycle time, false positives). Capture auditor feedback on packet usability.

Days 61–90

  • Scale: Expand NDC coverage and locations; parameterize rules by service line. Automate replenishment suggestions and wholesaler/TPA integrations.
  • Monitoring and QA: Establish weekly dashboards and control charts; institute periodic rule reviews.
  • Stakeholder alignment: Share ROI and compliance outcomes with pharmacy leadership, finance, and compliance to green‑light broader rollout.

9. Industry-Specific Considerations

  • Mixed‑use hospitals: Treat location and encounter typing with precision to avoid inadvertent diversion. Document inpatient/outpatient windows explicitly.
  • Contract pharmacies: Keep accumulators and replenishment logic clearly partitioned; ensure separate evidence packets per pharmacy and contract.
  • Manufacturer and payer nuances: Encode exclusions and contract attributes as policy data, not code, to adapt quickly to updates.
  • Evidence expectations: Auditors want the “why,” not just the “what.” Include rule versions, data snapshots, and unit conversions in every packet.

10. Conclusion / Next Steps

Agentic AI on Databricks turns split‑billing from a scramble into a governed, auditable workflow. By reconciling purchasing, dispensing, eligibility, and accumulators—and by auto‑assembling evidence—you reduce write‑offs, cut audit prep time, and improve confidence.

If your team is lean and the stakes are high, a partner that understands governance and operations accelerates the journey. Kriv AI, a governed AI and agentic automation partner focused on mid‑market organizations, helps with data readiness, MLOps, and policy‑as‑data design so your 340B program scales without sacrificing control. If you’re exploring governed Agentic AI for your mid‑market organization, Kriv AI can serve as your operational and governance backbone.

Explore our related services: AI Readiness & Governance · Agentic AI & Automation